Anavex Life Sciences Corp (AVXL)

[stealthways]

Recent grant details for epilepsy:

"Johns Hopkins University (JHU) was awarded an estimated $7.5 million grant from the National Institutes of Health (NIH) to clinically test an Alzheimer's drug, which could possibly delay or stop the onset of the disease.

The 5-year grant will fund the ongoing HOPE4MCl Phase 3 clinical trial for AGB101 (a proprietary low-dose formulation of levetiracetam that is used as an anticonvulsant usually given to treat certain kinds of seizures in patient with epilepsy.). The research previously spearheaded by neuroscientist Michela Gallagher found that this drug when given to patients with amnestic mild cognitive impairment appears to calm brain's hyperactivity."

This JCU grant is to treat the symptoms and not the cause. Since 2-73 works on upstream pathology , and has very positive results to date, a grant would seem to be a good possibility...